Search
for
Sort by
Research 151–180 of 1000+
- Minoxidil may suppress androgen receptor-related functions
- Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study
- 5-Alpha-Reductase Inhibitors and Combination Therapy
- Hair loss
- 25 years of ERβ: a personal journey
- Alopecia - the search for novel agents continues
- Impact of androgen deprivation therapy on mortality of prostate cancer patients with COVID-19: a propensity score-based analysis
- Non-surgical management of BPH: An updated review of current literature and state of the art on natural compounds and medical therapy
- 5α-Reductase Inhibitors Do Not Prevent the Development and Progression of Urothelial Cancer: In Vitro Evidence
- Hair aging and anti-aging
- Nonscarring hair loss disorders
- Bioavailability File: Bicalutamide
- Current Landscape and Emerging Therapies in Hair Loss Treatment for Androgenetic Alopecia
- Hormonal Control of Cardiac Action Potential Phase 1 Currents in the Brugada Syndrome
- Polycystic Ovary Syndrome: Update on Diagnosis and Treatment
- Female pattern hair loss
- A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women.
- Antiandrogen Therapy for Skin and Hair Disease
- Antiandrogen therapy for androgenetic alopecia
- A controlled study of the effects of RU58841, a non-steroidal antiandrogen, on human hair production by balding scalp grafts maintained on testosterone-conditioned nude mice
- Androgens/Androgen Receptor in the Management of Skin Diseases
- Medical Management Options for Hair Loss
- Chronic inflammatory diseases are stimulated by current lifestyle: how diet, stress levels and medication prevent our body from recovering
- What causes hidradenitis suppurativa ?—15 years after
- DRUG‐ASSOCIATED ALOPECIA
- The Effect of 5 -Reductase Inhibitors on Erectile Function
- Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double-Blind Randomized Controlled Trial
- Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review
- Abiraterone and spironolactone in prostate cancer: a combination to avoid
- Effects of <i>In Utero</i> Exposure to D-004, a Lipid Extract from <i>Roystonea regia</i> Fruits, in the Male Rat: A Comparison with Finasteride